DRESS
The Relapse
6 questions
Question 1 · Back again
Correct answer: Relapse following too rapid a steroid withdrawal
Why
Relapse after steroid reduction is characteristic of DRESS, and a ten-day course is far shorter than the disease requires.
The taper is measured in weeks, and the reason it gets shortened is that every other steroid indication an F1 meets uses a burst of a few days.
The picture is the original one returning — same eosinophilia, same hepatitis — in a patient who has taken nothing new.
Key point
Relapse follows a fast wean. Ten days is an asthma course, not a DRESS course.
Question 2 · Checking the obvious
Correct answer: That no cross-reacting drug has been started — the aromatic anticonvulsants cross-react
Why
Carbamazepine, phenytoin, lamotrigine and phenobarbital cross-react with each other. A patient taken off carbamazepine is very likely to have been started on something for the same indication, and if it is an aromatic anticonvulsant, that is a rechallenge in all but name.
So the first thing to do is read his current drug chart and his GP record against the class, not just against the single drug name.
It is also the reason the allergy alert must name the class, not one drug.
Key point
Check what replaced it. Aromatic anticonvulsants cross-react, so the substitute may be the culprit.
Question 3 · Reactivation
Correct answer: Reactivation of herpesviruses such as HHV-6, EBV and CMV
Why
Herpesvirus reactivation — HHV-6 in particular, along with EBV and CMV — is associated with DRESS and with its relapsing course. It is part of why this disease behaves differently from other drug eruptions.
For an F1, the practical implication is not to order the virology yourself but to know that relapse is expected behaviour, so a returning patient is not evidence that the original diagnosis was wrong.
This is dermatology and sometimes infectious diseases territory.
Key point
Herpesvirus reactivation is part of the picture. Relapse is the disease behaving normally.
Question 4 · Restarting treatment
Correct answer: A slow taper over weeks with planned review at each reduction
Why
Slow, over weeks, with review built in. The failure last time was the shape of the course rather than the dose.
Typical starting doses are 0.5-1 mg/kg/day for organ involvement, with topical steroids and emollients where the disease is skin-limited.
The review points matter because each reduction is where relapse shows itself, and somebody needs to be looking at the point it happens rather than six weeks later in an emergency department.
Key point
Slow taper with review at each step down. The reductions are where relapse appears.
Question 5 · The late complication
Correct answer: Thyroid function tests
Why
Autoimmune thyroiditis is a recognised late complication of DRESS, appearing months afterwards when everyone has moved on, and TFTs at convalescent follow-up, around 2-3 months, is the standard safety net.
It is easy to miss because the symptoms — fatigue, weight change, low mood — get attributed to the illness he has just been through.
Tryptase belongs to anaphylaxis. Bone protection is a reasonable thought given prolonged steroids, but it is not the DRESS-specific test.
Key point
TFTs at convalescent follow-up. Late thyroiditis is the complication nobody is looking for.
Question 6 · What he leaves with
Correct answer: The diagnosis, the culprit drug AND its cross-reacting class, and what a relapse looks like
Why
He is the most reliable barrier against rechallenge, and he can only do that job if he knows the class, not just the one drug name.
He also needs to know what a relapse looks like and when to come back — because relapse is expected, and this admission happened partly because nobody told him.
The taper schedule matters too, and belongs in the same document rather than instead of it.
Key point
Diagnosis, drug, class, and what relapse looks like — in writing.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.